| 영문 | shunt | 한글 | 지름길, 지름술, 단락 |
|---|---|---|---|
| 설명 | 1. 한쪽으로 돌아가다, 전환하다, 우회하다. 2. 혈관간의 통로 또는 연결. |
||
| B-T shunt | Blalock-Taussig shunt |
|---|---|
| HMP Shunt | Hexose Mono-Phosphate Shunt |
| LP shunt | Lumbo-Peritoneal shunt |
| VA shunt | Ventriculo-Atrial shunt |
| VP shunt | Ventriculo-Peritoneal shunt |
| PPP | Pentose phosphate pathways |
|---|---|
| DSRS | Distal splenorenal shunt |
| HMPS | Hexose monophosphate shunt |
| HMS | Hexose-monophosphate shunt |
| PVS | Peritoneo Venous Shunt |
pentose nucleic acid (펜토스 핵산
| pentose monophosphate shunt | <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate. Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses. In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection. Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose. (18 Nov 1997) |
|---|---|
| pentose | <chemistry> Sugar (monosaccharide) with five carbon atoms. Include ribose and deoxyribose of nucleic acids and many others such as the aldoses arabinose and xylose and the ketoses ribulose and xylulose. (12 Dec 1998) |
| pentose phosphate cycle | <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate. Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses. In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection. Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose. (18 Nov 1997) |
| pentose phosphate pathway | <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate. Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses. In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection. Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose. (18 Nov 1997) |
| arteriovenous shunt | <anatomy, surgery> A direct connection between an artery and vein. Most often due to the surgical joining of an artery and a vein under the skin for the purpose of haemodialysis. Larger arteriovenous shunts can create significant extra workload on the heart since arterial blood is diverted back to the venous circulation before it has a chance to deliver nutrients and oxygen to the body tissues. (20 Jun 2000) |
| A-V shunt | <anatomy, surgery> A direct connection between an artery and vein. Most often due to the surgical joining of an artery and a vein under the skin for the purpose of haemodialysis. Larger arteriovenous shunts can create significant extra workload on the heart since arterial blood is diverted back to the venous circulation before it has a chance to deliver nutrients and oxygen to the body tissues. (20 Jun 2000) |
| Blalock shunt | Subclavian artery to pulmonary artery shunt to increase pulmonary circulation in cyanotic heart disease with decreased pulmonary flow. (05 Mar 2000) |
| Blalock-Taussig shunt | A palliative subclavian artery to pulmonary artery anastomosis. (05 Mar 2000) |
| Rapoport-Luebering shunt | Part of the glycolytic pathway characteristic of human erythrocytes in which 2,3-bisphosphoglycerate (2,3-P2Gri) is formed as an intermediate between 1,3-P2Gri and 3-phosphoglycerate; 2,3-P2Gri is an important regulator of the affinity of haemoglobin for oxygen. (05 Mar 2000) |
| ventriculoperitoneal shunt | <procedure> A surgical procedure to insert a communicating catheter to relieve intracranial pressure caused by hydrocephalus. In this procedure the cerebrospinal fluid is shunted from the ventricles of the brain into the peritoneal cavity via a surgically implanted tube. (27 Sep 1997) |
| Glenn shunt | A means of palliating cyanotic heart disease by anastomosing the right pulmonary artery to the superior vena cava. Synonym: cavopulmonary shunt, Glenn shunt. (05 Mar 2000) |
| cavopulmonary shunt | A means of palliating cyanotic heart disease by anastomosing the right pulmonary artery to the superior vena cava. Synonym: cavopulmonary shunt, Glenn shunt. (05 Mar 2000) |
| renal-splenic venous shunt | Anastomosis of the splenic vein to the left renal vein, usually end-to-side, for control of portal hypertension. Synonym: renal-splenic venous shunt. (05 Mar 2000) |
| vp shunt | <procedure> A surgical procedure to insert a communicating catheter to relieve intracranial pressure caused by hydrocephalus. In this procedure the cerebrospinal fluid is shunted from the ventricles of the brain into the peritoneal cavity via a surgically implanted tube. (27 Sep 1997) |
| reversed shunt | Right-to-left shunt that had previously been a left-to-right shunt; rarely the opposite. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|